Literature DB >> 6772932

Replication of Borna disease virus in cell cultures.

S Herzog, R Rott.   

Abstract

Borna disease (BD) virus from infected brain tissue of horses or rabbits could be grown in embryonic brain cells from rabbits or rats with high virus yields. The cells became persistently infected and could be subcultivated without loss of infectivity. Cocultivation of infected rabbit brain (ERB) cells with GMK-, Vero-, or MDCK-cells led to persistently infected cell lines. BD virus grown in MDCK cells after cocultivation became adapted to this cell type and could be used directly for further infection of MDCK cells.

Entities:  

Mesh:

Year:  1980        PMID: 6772932     DOI: 10.1007/bf02122849

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  4 in total

1.  Studies of the mechanism of antigen stimulation of DNA synthesis in rabbit spleen cultures.

Authors:  G Harris
Journal:  Immunology       Date:  1965-12       Impact factor: 7.397

2.  Borna disease (BD), a slow virus infection. Biological properties of the virus.

Authors:  T H Ludwig; H Becht; L Groh
Journal:  Med Microbiol Immunol       Date:  1973       Impact factor: 3.402

3.  Kinetics of [3H]acetylcholine synthesis and release in primary cell cultures from mammalian CNS.

Authors:  H Bigalke; W Dimpfel
Journal:  J Neurochem       Date:  1978-04       Impact factor: 5.372

4.  In vitro studies on Borna virus. I. The use of cell cultures for the demonstration, titration and production of Borna virus.

Authors:  K Danner; D Heubeck; A Mayr
Journal:  Arch Virol       Date:  1978       Impact factor: 2.574

  4 in total
  77 in total

1.  Sequence variability of Borna disease virus: resistance to superinfection may contribute to high genome stability in persistently infected cells.

Authors:  S Formella; C Jehle; C Sauder; P Staeheli; M Schwemmle
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

2.  Preventive effects of early anti-CD4 or anti-CD8 treatment on Borna disease in rats.

Authors:  L Stitz; M Sobbe; T Bilzer
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

Review 3.  Borna disease virus and human disease.

Authors:  K M Carbone
Journal:  Clin Microbiol Rev       Date:  2001-07       Impact factor: 26.132

4.  Broad tissue and cell tropism of avian bornavirus in parrots with proventricular dilatation disease.

Authors:  Monika Rinder; Andreas Ackermann; Hermann Kempf; Bernd Kaspers; Rüdiger Korbel; Peter Staeheli
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

5.  Atypical dissemination of the highly neurotropic Borna disease virus during persistent infection in cyclosporine A-treated, immunosuppressed rats.

Authors:  L Stitz; D Schilken; K Frese
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

6.  Processing of the Borna disease virus glycoprotein gp94 by the subtilisin-like endoprotease furin.

Authors:  J A Richt; T Fürbringer; A Koch; I Pfeuffer; C Herden; I Bause-Niedrig; W Garten
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

7.  No evidence of Borna disease virus-specific antibodies in multiple sclerosis patients in Germany.

Authors:  B Kitze; S Herzog; P Rieckmann; S Poser; J Richt
Journal:  J Neurol       Date:  1996-09       Impact factor: 4.849

8.  Microplate hybridization for Borna disease virus RNA in human peripheral blood mononuclear cells.

Authors:  S Fujiwara; H Takahashi; T Nakaya; Y Nakamura; K Nakamura; K Iwahashi; H Kazamatsuri; S Iritani; N Kuroki; K Ikeda; K Ikuta
Journal:  Clin Diagn Lab Immunol       Date:  1997-05

9.  Borna disease virus (BDV), a nonsegmented RNA virus, replicates in the nuclei of infected cells where infectious BDV ribonucleoproteins are present.

Authors:  B Cubitt; J C de la Torre
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

10.  Persistence of Borna disease virus in naturally infected sheep.

Authors:  Thomas W Vahlenkamp; Andrea Konrath; Matthias Weber; Hermann Müller
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.